Company · CIK 0001038133 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances
HESKA CORP · HSKA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2015 MForm 4 → | May 18, 7:00 pm EDT | David E. SveenDirector | 7,224 | $10.19 | $73,607 | 7,224 | — | plan? |
| May 7, 2015 MForm 4 → | May 11, 3:20 pm EDT | G Irwin GordonDirector | 4,000 | $8.00 | $32,000 | 13,504 | — | plan? |
| Apr 22, 2015 SForm 4 → | Apr 24, 4:43 pm EDT | Robert B GrieveExecutive Chair, Director | 6,000 | $29.67 | $178,000 | 124,740 | −4.59% | plan? |
| Apr 13, 2015 SForm 4 → | Apr 15, 6:39 pm EDT | Robert B GrieveExecutive Chair, Director | 4,000 | $26.54 | $106,173 | 130,740 | −2.97% | plan? |
| Mar 10, 2015 SForm 4/A → | May 8, 3:57 pm EDT | Jason A NapolitanoChief Financial Officer | 5,765 | $26.02 | $149,989 | 83,632 | −6.45% | plan? |
| Mar 10, 2015 SForm 4/A → | Mar 12, 5:00 pm EDT | Jason A NapolitanoChief Financial Officer | 5,765 | $26.02 | $150,005 | 83,632 | −6.45% | plan? amended |
| Mar 9, 2015 SForm 4 → | Mar 11, 1:09 pm EDT | Robert B GrieveExecutive Chair, Director | 2,000 | $25.26 | $50,510 | 134,740 | −1.46% | plan? |
| Mar 9, 2015 FMForm 4 → | Mar 11, 1:08 pm EDT | William A AylesworthDirector | 9,142 | $18.25 | $166,842 | 37,397 | — | plan? |
| Mar 9, 2015 SForm 4 → | Mar 11, 1:06 pm EDT | Jason A NapolitanoChief Financial Officer | 5,765 | $26.02 | $149,989 | 83,632 | −6.45% | plan? |
| Mar 9, 2015 SForm 4 → | Mar 11, 1:03 pm EDT | Kevin S. WilsonCEO and President, Director | 10,000 | $25.38 | $253,778 | 251,810 | −3.82% | plan? |
| Feb 3, 2015 FMForm 4 → | Feb 5, 4:20 pm EST | Robert B GrieveExecutive Chair, Director | 43,380 | $13.20 | $572,832 | 136,740 | — | plan? |
| Feb 2, 2015 FMForm 4 → | Feb 4, 4:33 pm EST | Jason A NapolitanoChief Financial Officer | 31,664 | $13.24 | $419,137 | 89,397 | — | plan? |
| Jan 16, 2015 MForm 4 → | Feb 2, 5:46 pm EST | Nancy WisnewskiEVP, Prod. Dev. & Cust. Supp | 6,500 | $8.80 | $57,200 | 14,018 | — | plan? late |
| Nov 16, 2012 SForm 4 → | Aug 4, 2016, 5:04 pm EDT | Sharon L. RileyDirector | 1,000 | $8.09 | $8,086 | 0 | −100% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:35 pm EST | Steven M. EylEVP, Commercial Operations | 11,000 | — | — | 11,000 | — | |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:34 pm EST | Nancy WisnewskiEVP, Prod. Dev. & Cust. Supp | 11,000 | — | — | 9,734 | — | |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:33 pm EST | Steve AsakowiczEVP, Comp. Animal Health Sales | 11,000 | — | — | 11,000 | — | |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:31 pm EST | Rod LippincottEVP, Comp. Animal Health Sales | 11,000 | — | — | 11,000 | — | |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:30 pm EST | Jason A NapolitanoExec. VP, CFO & Secretary | 14,000 | — | — | 13,281 | — | |
| Dec 31, 2014 AForm 4 → | Jan 5, 2015, 4:29 pm EST | Michael J McGinleyPresi, Biologic. & Pharm. | 14,000 | — | — | 13,710 | — |